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Opportunistic Candida species often have to cope with inhibitory concentrations of acetic
acid, in the acidic environment of the vaginal mucosa. Given that the ability of these yeast
species to tolerate stress induced by weak acids and antifungal drugs appears to be a
key factor in their persistence and virulence, it is crucial to understand the underlying
mechanisms. In this study, the drug:H+ antiporter CgAqr1 (ORF CAGL0J09944g), from
Candida glabrata, was identiﬁed as a determinant of resistance to acetic acid, and also
to the antifungal agents ﬂucytosine and, less signiﬁcantly, clotrimazole. These antifungals
were found to act synergistically with acetic acid against this pathogen. The action of
CgAqr1 in this phenomenon was analyzed. Using a green ﬂuorescent protein fusion,
CgAqr1 was found to localize to the plasma membrane and to membrane vesicles when
expressed in C. glabrata or, heterologously, in Saccharomyces cerevisiae. Given its ability
to complement the susceptibility phenotype of its S. cerevisiae homolog, ScAqr1, CgAqr1
was proposed to play a similar role in mediating the extrusion of chemical compounds.
Signiﬁcantly, the expression of this genewas found to reduce the intracellular accumulation
of 3H-ﬂucytosine and, to a moderate extent, of 3H-clotrimazole, consistent with a direct
role in antifungal drug efﬂux. Interestingly, no effect of CgAQR1 deletion could be found
on the intracellular accumulation of 14C-acetic acid, suggesting that its role in acetic
acid resistance may be indirect, presumably through the transport of a still unidentiﬁed
physiological substrate. Although neither of the tested chemicals induces changes in
CgAQR1 expression, pre-exposure to ﬂucytosine or clotrimazole was found to make C.
glabrata cellsmore sensitive to acetic acid stress. Results from this study show that CgAqr1
is an antifungal drug resistance determinant and raise the hypothesis that it may play a role
in C. glabrata persistent colonization and multidrug resistance.
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INTRODUCTION
Infections caused by Candida species are a problem of increasing
clinical signiﬁcance. Candida glabrata infections rank second in
frequency, immediately after those caused by C. albicans (Jarvis,
1995). Although many Candida species can be found in the gas-
trointestinal and genital tract of healthy individuals as innocuous
commensals, in immunocompromised hosts they are able to cause
skin infections, which may in term lead to invasive infections. In
any case, to sense and adapt to different niches within the host
environment is essential for their survival and persistence, both as
commensals and infection agents.
One of the factors that vary the most within Candida coloniza-
tion sites is pH. Indeed, Candida species appear to be suited to
thrive in a pH range varying from more than 7.0, as found in the
bloodstream, to nearly 4.0, exhibited by the vulvovaginal mucosa.
Variation in host niche pH has been seen to affect drug resistance,
but the underlying molecular mechanisms are still unclear. Some
clues on the mechanisms of the response to pH changes were
identiﬁed in C. albicans. For example, in C. albicans, the Rim101
pathway has been shown to be activated under alkaline pH, such
as that met during systemic candidiasis (pH 7.4). Rim101 activates
the transcription of the PHR1 gene and represses that of the PHR2
gene, encoding homologous cell wall β-glycosidases. While Phr1
is required for virulence at alkaline pH, Phr2 is required for viru-
lence at acidic pH, such as that met during vaginal infection (pH
4.0; reviewed in Davis, 2009; Selvig and Alspaugh, 2011). How-
ever, little is known on the mechanisms of response and resistance
to acidiﬁcation caused by, or occurring in the presence of weak
organic acids, whose concentration reaches quite high values in
some colonization or infection sites. Indeed, the concentration of
lactic or acetic acid, can reach up to 125 mM in the vaginal tract,
particularly under bacterial vaginosis (Chaudry et al., 2004). This
is an important issue since the inhibitory effect exerted by weak
acids, that dissociate directly in the cytosol leading to intracellular
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acidiﬁcation, is much stronger than that exerted by low extra-
cellular pH per se (Mira et al., 2010). Furthermore, the presence
of inhibitory or close-to-inhibitory concentrations of these weak
acids is likely to interfere with the action of antifungal therapy
and, presumably, could also play a role in the induction of mul-
tidrug resistance acquisition. For example, ﬂuconazole has been
shown to act synergistically with acetic acid in its antifungal action
against C. albicans. Indeed, its fungicidal activity in vaginal fungal
infections appears to be due speciﬁcally to the natural existence of
weak organic acids in this niche (Moosa et al., 2004).
Within the context of factors conferring resistance toweak acids
and drugs, it is interesting to point out that some of the multidrug
resistance efﬂux pumps from the major facilitator superfamily
(MFS) characterized in S. cerevisiae play a role in weak acid stress
resistance (Sá-Correia et al., 2009; Mira et al., 2010). This is the
case of the drug:H+ antiporters Aqr1 (Tenreiro et al., 2002), Azr1
(Tenreiro et al., 2000), Tpo2, and Tpo3 (Fernandes et al., 2005),
which have been shown to confer resistance to short chain mono-
carboxylic acids such as acetic and propionic acids. Among these,
Aqr1 stands out as conferring resistance to weak acids, but also to
chemical stress inducers such as the antimalarial/antiarrhythmic
drug quinidine, the cationic dye crystal violet, or, less clearly, the
antifungal drug ketoconazole (Tenreiro et al., 2002). ScAqr1 was
further seen to be involved in the excretion of amino acids, par-
ticularly homoserine, threonine, alanine, aspartate, and glutamate
(Velasco et al., 2004).
This paper describes the functional analysis of the C. glabrata
CgAQR1 gene (ORF CAGL0J09944g), sharing a high degree of
homology with S. cerevisiae AQR1 gene, with emphasis on its
dual role in acetic acid and antifungal drug resistance. The pos-
sible synergy of acetic acid and the antifungal drugs to which
CgAqr1 confers resistance to and the ability of acetic acid to
induce cross-resistance against antifungal drugs was examined.
The sub-cellular localization of this transporter was assessed in
C. glabrata and its action in reducing the intracellular accumula-
tion of 3H-ﬂucytosine, 3H-clotrimazole, and 14C-acetic acid, in
C. glabrata cells was evaluated. This study provides an insight into
the cross-talk between weak acid and antifungal drug action and
resistance, as mediated by CgAqr1, with expected impact in the
persistence and multidrug resistance phenotypes exhibited by C.
glabrata within acidic infection sites in the human host.
MATERIALS AND METHODS
STRAINS, PLASMIDS, AND GROWTH MEDIA
Saccharomyces cerevisiae strain BY4741 (MATa, ura30, leu20,
his31, met150) and the derived single deletion mutant
BY4741_aqr1 were obtained from the Euroscarf collection. The
CBS138 C. glabrata strain, whose genome sequence was released
in 2004, andKUE100 (Ueno et al., 2007) were used in this study. C.
glabrata strain L5U1 (cgura30, cgleu20) was kindly provided
by John Bennett (Chen et al., 2007), from the National Institute of
Allergy and Infectious Diseases, NIH,Bethesda, USA. The plasmid
pGREG576 was obtained from the Drag&Drop collection (Jansen
et al., 2005).
Cells were batch-cultured at 30◦C, with orbital agitation
(250 rpm) in yeast extract peptone dextrose (YPD) growth media,
with the following composition: 20 g glucose (Merck), 20 g yeast
extract (Difco), and 10 g peptone (Difco). For some of the
experiments, minimal medium was used, resulting from differ-
ent amino acid supplementation of the basal medium (BM) with
the following composition (per liter): 1.7 g yeast nitrogen base
without amino acids or NH+4 (Difco), 20 g glucose (Merck), and
2.65 g (NH4)2SO4 (Merck). S. cerevisiae wild-type and derived
BY4741 strains were grown in MM4 medium that resulted from
BM supplementation with 20 mg/1 methionine, 20 mg/1 histi-
dine, 60 mg/1 leucine, and 20 mg/1 uracil (all from Sigma). C.
glabrata strains derived from CBS138 and KUE100 or L5U1 were
cultured in BM medium without supplementation or with the
supplementation of 20 mg/l uracil and 60 mg/l leucine, respec-
tively. To maintain selective pressure over the recombinant strains,
the addition of uracil to this medium was only carried out to grow
the host yeast cells. Agarized solid media contained, besides the
above-indicated ingredients, 20 g/l agar (Iberagar).
CLONING OF THE C. glabrata CgAQR1 GENE (ORF CAGL0J09944g)
The pGREG576 plasmid from the Drag&Drop collection (Jansen
et al., 2005) was used to clone and express the C. glabrata ORF
CAGL0J09944g in S. cerevisiae, as described before for other het-
erologous genes (Cabrito et al., 2009). pGREG576 was acquired
from Euroscarf and contains a galactose inducible promoter
(GAL1), the yeast selectable marker URA3 and the GFP gene,
encoding a green ﬂuorescent protein (GFPS65T), which allows
monitoring of the expression and sub-cellular localization of
the cloned fusion protein. CAGL0J09944g DNA was generated
by PCR, using genomic DNA extracted from the sequenced
CBS138 C. glabrata strain, and the following speciﬁc primers: 5′-
GAATTCGATATCAAGCTTATCGATACCGTCGACAATGGTGGA
AAGTGGTCCAC-3′ and 5′-GCGTGACATAACTAATTACATGAC
TCGAGGTCGACCGTTATCATACTTTTTCTTCAG-3′. Thedesig-
ned primers contain, besides a region with homology to the
ﬁrst 19 and the last 22 nucleotides of the CAGL0J09944g cod-
ing region (italic), nucleotide sequences with homology to the
cloning site ﬂanking regions of the pGREG576 vector (under-
lined). The ampliﬁed fragment was co-transformed into the
parental S. cerevisiae strain BY4741 with the pGREG576 vec-
tor, previously cut with the restriction enzyme SalI, to obtain
the pGREG576_CgAQR1 plasmid. Since the GAL1 promoter only
allows a slight expression of downstream genes in C. glabrata, to
visualize by ﬂuorescence microscopy the sub-cellular localization
of the CgAQR1 gene in C. glabrata, a new construct was obtained.
The GAL1 promoter present in the pGREG576_CgAQR1 plasmid
was replaced by the copper-inducible MTI C. glabrata promoter
(Willins et al., 2002), giving rise to the pGREG576_MTI_CgAQR1
plasmid. The MTI promoter DNA was generated by PCR,
using genomic DNA extracted from the sequenced CBS138
C. glabrata strain, and the following speciﬁc primers: 5′-
TTAACCCTCACTAAAGGGAACAAAAGCTGGAGCTCTGTACG
ACACGCATCATGTGGCAATC-3′ and 5′-GAAAAGTTCTTCTCC
TTTACTCATACTAGTGCGGCTGTGTTTGTTTTTGTATGTGTT
TGTTG-3′. The designed primers contain, besides a region
with homology to the ﬁrst and last 19 nucleotides of the
ﬁrst 1000 bp of the MTI promoter region (italic), nucleotide
sequences with homology to the cloning site ﬂanking regions
of the pGREG576 vector (underlined). The ampliﬁed fragment
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was co-transformed into the parental strain BY4741 with the
pGREG576_CgAQR1 plasmid, previously cut with SacI and NotI
restriction enzymes to remove the GAL1 promoter, to generate
the pGREG576_MTI_CgAQR1 plasmid. The recombinant plas-
mids pGREG576_CgAQR1 and pGREG576_MTI_CgAQR1 were
obtained through homologous recombination in S. cerevisiae and
veriﬁed by DNA sequencing.
DISRUPTION OF THE C. glabrata CgAQR1 GENE (ORF
CAGL0J09944g)
The deletion of the CgAQR1 gene was carried out in the
parental strain KUE100, using the method described by Ueno
et al. (2011). The target gene CAGL0J09944g (CgAQR1) was
replaced by a DNA cassette including the CgHIS3 gene,
through homologous recombination. The replacement cas-
sette was prepared by PCR using the following primers: 5′-
CGTGATCAGCGGCCCGTTATTATTATAGTTTCTTATCTTTTT
TTCGTGATGTCCAAAGTTGCCATGTAAA-3′ and 5′-CCAGCC
TCACGATGTGATAACGAAACGAAACTCAAAATTACCCAAAA
TTACCCACAATCAAAACCTAATA-3′. The pHIS906 plasmid
including CgHIS3 was used as a template and transformation was
performed as described previously (Ueno et al., 2007). Recombi-
nation locus and gene deletion were veriﬁed by PCR using the
following pair of primers: 5′-CTCGTCGTCAGAGTCGTAGT-3′
and 5′-AGAAAACCAGCCTCACGATG-3′.
SUSCEPTIBILITY ASSAYS IN C. glabrata
The susceptibility of the parental strain KUE100 toward toxic con-
centrations of the selected drugs and acetic acid was compared
to that of the deletion mutant KUE100_Dcgaqr1 by spot assays
or cultivation in liquid growth medium. The ability of CgAQR1
gene expression to increase wild-type resistance to the tested
chemical stresses was also examined through spot assays in the
URA3− strain L5U1, using the pGREG576_CgAQR1 centromeric
plasmid.
KUE100 C. glabrata cell suspensions used to inoculate the agar
platesweremid-exponential cells grown in basal BMmediumuntil
culture OD600 nm = 0.4 ± 0.02 was reached and then diluted in
sterile water to obtain suspensions with OD600 nm = 0.05 ± 0.005.
These cell suspensions and subsequent dilutions (1:5; 1:25)
were applied as 4 μl spots onto the surface of agarized BM
medium, supplemented with adequate chemical stress concentra-
tions. The tested drugs included the following compounds, used
in the speciﬁed concentration ranges: the azole antifungal drugs
ﬂuconazole (10–200 mg/l), ketoconazole (10–50 mg/l), clotri-
mazole (1–20 mg/l), tioconazole (0.2–1 mg/l), and miconazole
(0.2–1 mg/l), the polyene antifungal drug amphotericin B (0.1–
0.5 mg/l), the ﬂuoropyrimidine 5-ﬂucytosine (0.02–5 mg/l), and
the antimalarial/antiarrhythmic drug quinidine (3–9 mg/ml; all
from Sigma). L5U1 C. glabrata cell suspensions used to inocu-
late the agar plates were mid-exponential cells grown in basal BM
medium, containing 0.5% glucose and 0.1% galactose, without
uracil when harboring the pGREG576-derived plasmids, until cul-
ture OD600 nm = 0.4± 0.02 was reached and then diluted in sterile
water to obtain suspensions with OD600 nm = 0.05 ± 0.005. These
cell suspensions and subsequent dilutions (1:5; 1:25) were applied
as 4 μl spots onto the surface of agarized BM medium without
uracil, containing 0.1% glucose and 1% galactose, supplemented
with adequate chemical stress concentrations, within the above
described ranges.
KUE100 C. glabrata cell suspensions used for susceptibility
assays in liquid medium were grown to mid-exponential phase
(OD600 nm = 0.4 ± 0.02) in basal BM medium, harvested by ﬁl-
tration and re-suspended in fresh BM medium, supplemented
or not with the speciﬁed concentrations of acetic acid, clotrima-
zole, or 5-ﬂucytosine, with an initial OD600 nm = 0.05 ± 0.005.
Growth, taking place in Erlenmeyer ﬂasks, at 37◦C, 250 rpm, was
followed by measuring the optical density of the cell suspension at
600 nm.
SUSCEPTIBILITY ASSAYS IN S. cerevisiae
The susceptibility of the parental strain BY4741 toward toxic con-
centrations of the selected drugs and acetic acid was compared
to that of the deletion mutant BY4741_Daqr1 by spot assays. The
ability of CgAQR1 gene expression to increase wild-type resistance
to the tested chemical stresses and to complement the suscepti-
bility phenotype exhibited by the BY4741_Daqr1 single deletion
mutants was also examined, using the pGREG576_CgAQR1 cen-
tromeric plasmid in which CgAQR1 is expressed under the GAL1
promoter.
Saccharomyces cerevisiae cell suspensions used to inoculate the
agar plates were mid-exponential cells grown in basal MM4-U
medium, containing 0.5% glucose and 0.1% galactose, until cul-
ture OD600 nm = 0.4 ± 0.02 was reached and then diluted in
sterile water to obtain suspensions with OD600 nm = 0.05 ± 0.005.
These cell suspensions and subsequent dilutions (1:5; 1:25) were
applied as 4 μl spots onto the surface of agarized MM4-U
medium, containing 0.1% glucose and 1% galactose, supple-
mented with adequate chemical stress concentrations. The tested
drugs and other xenobiotics included the following compounds,
used in the speciﬁed concentration ranges: the azole antifun-
gal drugs ﬂuconazole (50–200 mg/l), itraconazole (40–80 mg/l),
ketoconazole (10–50 mg/l), clotrimazole (1–20 mg/l), tioconazole
(0.05–0.2mg/l), andmiconazole (0.05–0.2mg/l), the polyene anti-
fungal drug amphotericin B (0.05–0.5 mg/l), the ﬂuoropyrimidine
5-ﬂucytosine (0.02–5mg/l), and theweak organicmonocarboxylic
acid acetic acid (30–60 mM) (all from Sigma).
CgAqr1 SUB-CELLULAR LOCALIZATION ASSESSMENT
The sub-cellular localization of the CgAqr1 protein was deter-
mined based on the observation of BY4741 S. cerevisiae or
L5U1 C. glabrata cells transformed with the pGREG576-CgAQR1
or pGREG576-MTI-CgAQR1 plasmids, respectively. These cells
express the CgAqr1_GFP fusion protein, whose localization may
be determined using ﬂuorescence microscopy. S. cerevisiae cell
suspensions were prepared by cultivation in MM4-U medium,
containing 0.5% glucose and 0.1% galactose, at 30◦C, with orbital
shaking (250 rev/min), until a standard cultureOD600 nm (Optical
Density at 600 nm) = 0.4 ± 0.04 was reached. At this point cells
were transferred to the same medium containing 0.1% glucose
and 1% galactose, to induce protein expression. C. glabrata cell
suspensions were prepared in BM-U medium, until a standard
culture OD600 nm = 0.4 ± 0.04 was reached, and transferred to
the same medium supplemented with 30 μM CuSO4 (Sigma), to
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induce protein over-expression. After 5 h of incubation, the dis-
tribution of CgAqr1_GFP fusion protein in S. cerevisiae or in C.
glabrata living cells was detected by ﬂuorescence microscopy in a
Zeiss Axioplan microscope (Carl Zeiss MicroImaging), using exci-
tation and emission wavelength of 395 and 509 nm, respectively.
Fluorescence images were captured using a cooled CCD camera
(Cool SNAPFX, Roper Scientiﬁc Photometrics).
TRANSPORT ASSAYS USING RADIOLABELED COMPOUNDS
[3H]-ﬂucytosine, [3H]-clotrimazole, and [14C]-acetate accumu-
lation assays were carried out as described before (Vargas et al.,
2004). To estimate the accumulation of each radiolabeled com-
pound (intracellular/extracellular) in yeast cells, the parental strain
KUE100 and the mutant strain KUE100_Dcgaqr1 were grown in
BM medium till mid-exponential phase and harvested by ﬁltra-
tion. Cells were washed and re-suspended in BM medium, to
obtain dense cell suspensions [OD600 nm = 5.0 ± 0.1, equiv-
alent to approximately 2.2 mg (dry weight)/ml]. After 5 min
incubation at 30◦C, with agitation (150 rpm), the radiolabeled
compound was added to the cell suspensions [1 μM of [3H]-
ﬂucytosine (American Radiolabeled Chemicals; 1 mCi/ml) and
3 mg/l of unlabeled ﬂucytosine; or 0.1 μM of [3H]-clotrimazole
(American Radiolabeled Chemicals; 1 mCi/ml) and 75 mg/l of
unlabeled clotrimazole; 3.5 μM of [14C]-acetic acid (American
Radiolabeled Chemicals; 0.1 mCi/ml) and 100 mM of unlabeled
acetic acid]. The accumulation of each radiolabeled compound
was followed, in individual assays, for an additional period of
30 min until equilibrium was reached. In all cases, the intracel-
lular accumulation of the radiolabeled compound was followed
by ﬁltering 200 μl of cell suspension, at adequate time intervals,
through pre-wetted glass microﬁber ﬁlters (Whatman GF/C). The
ﬁlters were washed with ice-cold TM buffer and the radioactivity
measured in aBeckmanLS5000TDscintillation counter. Extracel-
lular concentration of the radiolabeled compound was estimated,
by radioactivity assessment of 50 μl of the supernatant.
Non-speciﬁc adsorption of each radiolabeled compound to the
ﬁlters and to the cells (less than 5% of the total radioactivity) was
assessed and taken into consideration. To calculate the intracellular
concentration of each radiolabeled compound, the internal cell
volume (V i) of the exponential cells, grown in the absence of drug
and used for accumulation assays, was considered constant and
equal to 2.5 μl/mg dry weight (Rosa and Sá-Correia, 1996).
CgAqr1 EXPRESSION MEASUREMENTS
The levels of CgAQR1 transcripts in C. glabrata cells were assessed
by quantitative real-time PCR. Total RNA samples were obtained
from cell suspensions harvested in control conditions (mid-
exponential phase cells in the absence of drugs) or upon 1 h
of exposure to 75 mg/l clotrimazole or 3.5 mg/l ﬂucytosine or
60 mM acetic acid. Synthesis of cDNA for real-time RT-PCR
experiments, from total RNA samples, was performed using the
MultiscribeTM reverse transcriptase kit (Applied Biosystems) and
the 7500 RT-PCR Thermal Cycler Block (Applied Biosystems),
following the manufacturer’s instructions. The quantity of cDNA
for the following reactions was kept around 10 ng. The subse-
quent RT-PCR step was carried out using SYBR® Green reagents.
Primers for the ampliﬁcation of the CgAQR1 and CgACT1
cDNA were designed using Primer Express Software (Applied
Biosystems) and are 5′-GCTGATAAGTTCGGCCGTAGA-3′ and
5′-AATGGAGGCAACCACGTAGATC-3′ and 5′-AGAGCCGTCT
TCCCTTCCAT-3′ and 5′-TTGACCCATACCGACCATGA-3′, res-
pectively. The RT-PCR reaction was carried out using a thermal
cycler block (7500 Real-Time PCR System – Applied Biosystems).
Default parameters established by the manufacturer were used
and ﬂuorescence detected by the instrument and registered in an
ampliﬁcation plot (7500 System SDS Software – Applied Biosys-
tems). The CgACT1 mRNA level was used as an internal control.
The relative values obtained for thewild-type strain in control con-
ditionswere set as 1 and the remaining values are presented relative
to that control. To avoid false positive signals, the absence of non-
speciﬁc ampliﬁcation with the chosen primers was conﬁrmed by
the generation of a dissociation curve for each pair of primers.
RESULTS
CgAqr1 EXPRESSION CONFERS RESISTANCE TO ACETIC ACID
Given the previously observed effect of S. cerevisiae AQR1 gene
in weak acid stress tolerance (Tenreiro et al., 2002), the action of
CgAqr1 in acetic acid tolerance was inspected. The deletion of
CgAQR1 gene in C. glabrata clearly decreases its tolerance to an
inhibitory concentration of acetic acid (Figure 1). This is visible
both in spot assays (Figure 1A) and in liquid medium cultivation
(Figure 1B). Sudden exposure of un-adaptedwild-typeC. glabrata
cells to 60 mM acetic acid leads to 5 h of lag-phase followed by
growth resumption with reduced kinetics, while cells devoid of
CgAqr1 enter a lag-phase that lasts for around 18 h, before growth
resumption. Apparently, the absence of the Aqr1 gene affects only
slightly the growth rate at which cells are able to reassume expo-
nential growth in the presence of acetic acid, suggesting that its
role is mainly played during the adaptation to this stress (Table 1).
The introduction of a recombinant plasmid expressing CgAqr1
further increases C. glabrata natural resistance toward acetic acid,
when compared to the same strain harboring the corresponding
cloning vector (Figure 1C), reinforcing the ﬁnding that CgAqr1 is
a determinant of acetic acid resistance in C. glabrata.
CgAqr1 EXPRESSION CONFERS RESISTANCE TO FLUCYTOSINE AND
AZOLE ANTIFUNGAL DRUGS
The deletion of the CgAqr1 gene in C. glabrata was found, based
on spot assays, to increase the susceptibility of this pathogen
against the antifungal ﬂuoropyrimidine analog ﬂucytosine, and
the imidazole antifungal drugs miconazole, clotrimazole, and
tioconazole (Figure 2A). The introduction of a recombinant plas-
mid expressing CgAqr1 increases C. glabrata natural resistance
toward ﬂucytosine, but only very mildly against clotrimazole and
tioconazole, when compared to the same strain harboring the
corresponding cloning vector (Figure 2B), reinforcing the ﬁnd-
ing that CgAqr1 is a strong determinant of ﬂucytosine resistance
in C. glabrata. No effect of CgAqr1 expression could be clearly
detected in C. glabrata susceptibility to ﬂuconazole, itracona-
zole, or amphotericin B. The comparison of the growth curves
of wild-type and derived Dcgaqr1 cells in liquid medium show that
the deletion of CgAqr1 clearly impairs C. glabrata growth in the
presence of clotrimazole and, particularly, ﬂucytosine (Figure 3).
Indeed, although the growth curves of both strains are nearly
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FIGURE 1 | (A)Comparison of the susceptibility to inhibitory concentrations
of acetic acid, at the indicated concentration, of the C. glabrata KUE100 and
KUE100_Dcgaqr1 strains, in BM agar plates by spot assays.(B)Comparison of
growth curves of the C. glabrata KUE100 (♦,) and KUE100_Dcgaqr1 (,)
strains, in liquid BM medium, supplemented with 0 mM (♦,) or 60 mM
(,) of acetic acid.(C)Comparison of the susceptibility to inhibitory
concentrations of acetic acid, at the indicated concentration, of the
C. glabrata L5U1 strain, harboring the pGREG576 cloning vector (v) or
the pGREG576_CgAqr1 plasmid in BM agar plates, without uracil, by spot
assays. The inocula were prepared as described in Section “Materials
and Methods.” Cell suspensions used to prepare the spots were 1:5 (b)
and 1:25 (c) dilutions of the cell suspension used in (a). The displayed
images and growth curves are representative of at least three independent
experiments.
indistinguishable in control conditions, upon sudden exposure to
the presence of 3 mg/ml of ﬂucytosine the wild-type cells experi-
ence a period of around 18 h of lag-phase, followed by exponential
growth with a reduced rate, while the Dcgaqr1 deletion mutant
cells enter a period of lag-phase that last for around 35 h prior
to growth resumption with even more inhibited growth kinetics
(Table 1; Figure 3A). A less striking, but still clear, effect of CgAqr1
deletion can also be seen in the presence of 50 mg/ml of clotrima-
zole. Dcgaqr1 deletion mutant cells exhibit a period of lag-phase
of around 18 h prior to growth resumption, while the effect of this
concentration of clotrimazole in wild-type cells appears to be felt
mostly at the level of growth rate inhibition (Table 1; Figure 3B).
Using S. cerevisiae as a heterologous expression system, the
effect of cgaqr1 expression in yeast resistance to antifungal drugs
was further tested, in order to verify whether or not cgaqr1 is
able to functionally complement its S. cerevisiae homolog. The
deletion of the S. cerevisiae AQR1 gene was found to increase the
susceptibility toward ﬂucytosine, clotrimazole and, as observed
before (Tenreiro et al., 2002), acetic acid exhibited by the corre-
sponding parental strain (Figure 4). When expressed in the S.
cerevisiae Daqr1 background, the cgaqr1 gene was able to rescue all
the observed susceptibility phenotypes, further conﬁrming its role
in ﬂucytosine and imidazole drug resistance (Figure 4).
ACETIC ACID ACTS SYNERGISTICALLY WITH CLOTRIMAZOLE AND
FLUCYTOSINE
In order to evaluate the eventual effect of acetic acid, present in
some of the natural niches of Candida infection, in antifungal
therapy, the effect of co-exposure of C. glabrata cells to acetic acid
and to the antifungals clotrimazole and ﬂucytosine was examined.
C. glabrata wild-type cells were exposed to concentrations of acetic
acid, clotrimazole, and ﬂucytosine that, individually, do not affect
growth: 45 mM, 30 and 0.2 mg/l, respectively (Figure 5). However,
when in combination, the same “innocuous” concentrations of
acetic acid and clotrimazole or acetic acid and ﬂucytosine, were
found to lead to severe growth impairment. Indeed, when grown
in the presence of 30 mg/l clotrimazole plus 45 mM of acetic acid,
the C. glabrata population enters a period of 40 h of lag-phase,
followed by a drastically reduced growth rate and reaching lower
levels of ﬁnal biomass when compared to control cells (Figure 5).
Sudden exposure to 0.2 mg/l ﬂucytosine plus 45 mM of acetic
acid leads to an even longer period of lag-phase (50 h), upon
Table 1 | Comparison of the susceptibility to inhibitory concentrations
of acetic acid, clotrimazole, or flucytosine of the C. glabrata KUE100
and KUE100_Dcgaqr1 strains, based on the growth parameters
lag-phase duration, exponential growth rate, and final biomass.
Growth
conditions
Strain Lag-phase (h) Growth rate/h Final
biomass
(OD600 nm)
Control Wild-type nd 1.32 ± 0.08 9.76± 0.39
Daqr1 nd 1.23 ± 0.09 6.64± 0.96
Clotrimazole
50 mg/l
Wild-type 6.25 ± 2.71 0.20 ± 0.04 6.06± 0.09
Daqr1 17.96 ± 0.27 0.19 ± 0.01 3.00± 0.17
Flucytosine
3 mg/l
Wild-type 18.76 ± 0.13 0.30 ± 0.02 9.28± 0.51
Daqr1 35.14 ± 3.60 0.21 ± 0.07 4.06± 0.37
Acetic acid
60 mM
Wild-type 5.31 ± 2.86 0.19 ± 0.02 7.76± 0.45
Daqr1 18.28 ± 1.08 0.14 ± 0.001 2.36± 0.01
Values are the average of at least three independent experiments ± standard
deviation. Nd, not detected.
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FIGURE 2 | (A) Comparison of the susceptibility to antifungal drugs, at the
indicated concentrations, of the C. glabrata KUE100 and KUE100_Dcgaqr1
strains, in BM agar plates by spot assays. (B) Comparison of the susceptibility
to antifungal drugs, at the indicated concentrations, of the C. glabrata L5U1
strain, harboring the pGREG576 cloning vector (v) or the pGREG576_CgAqr1
plasmid in BM agar plates, without uracil, by spot assays. The inocula were
prepared as described in Section “Materials and Methods.” Cell suspensions
used to prepare the spots were 1:5 (b) and 1:25 (c) dilutions of the cell
suspension used in (a). The displayed images are representative of at least
three independent experiments.
which growth resumption is achieved (Figure 5). It is clear that
the inhibitory effect of C. glabrata exposure to acetic acid plus
ﬂucytosine or acetic acid plus clotrimazole is much stronger than
the sumof their individual inhibitory effects, suggesting that acetic
acid acts synergistically with ﬂucytosine and clotrimazole. In the
absence of CgAqr1, this effect seems to be even more pronounced.
Given the fact that ﬂucytosine is used mostly in combination with
ﬂuconazole, we further veriﬁed experimentally that ﬂucytosine
and ﬂuconazole do exhibit a synergistic effect. However, and as
expected based on the fact that CgAqr1 does not confer resistance
to ﬂuconazole, no increased role of CgAqr1 in the presence of this
combination of drugs was observed (results not shown).
CgAqr1 IS LOCALIZED TO THE PLASMA MEMBRANE AND
MEMBRANE VESICLES IN C. glabrata AND IN S. cerevisiae
Candida glabrata cells harboring the pGREG576_MTI_CgAQR1
plasmid were grown to mid-exponential phase in minimal
medium, and then transferred to the same medium containing
30 μM CuSO4, to promote protein expression in moderate con-
trolled levels. At a standard OD600 nm of 0.5 ± 0.05, obtained
after around 5 h of incubation, cells were inspected through ﬂu-
orescence microscopy. This period of incubation was found to
allow detectable protein expression levels, but not a high degree of
over-expression that may lead to mis-localization. In C. glabrata
cells, the CgAqr1_GFP fusion was found to be localized to the cell
periphery, and also to a punctuate distribution throughout the
cell (Figure 1A). Control cells, on the other hand, harboring the
pGREG576 cloning vector, displayed a slight anduniformdistribu-
tion of ﬂuorescence (Figure 6A), similar to what can be observed
as the host cells auto-ﬂuorescence. Since CgAqr1 is predicted to be
an integral membrane protein (Gbelska et al., 2006), these results
strongly suggest a plasma membrane and, eventually, membrane
vesicle localization, similar to what was observed for its S. cere-
visiae homolog Aqr1 (Tenreiro et al., 2002; Velasco et al., 2004).
S. cerevisiae cells harboring the pGREG576_CgAqr1 plasmid were
also tested for the sub-cellular localization of CgAqr1, to verify that
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FIGURE 3 | Comparison of the growth curves of C. glabrata KUE100
(♦, ) and KUE100_Dcgaqr1 (,) strains, in liquid BM medium,
in the absence (♦,) or presence of 3 mg/l flucytosine (A) or 50 mg/l
clotrimazole (B) (,).The inocula were prepared as described in Section
“Materials and Methods.”The displayed growth curves are representative
of at least three independent experiments.
FIGURE 4 | Comparison of the susceptibility to antifungal drugs and
acetic, at the indicated concentrations, of the S. cerevisiae BY4741 and
BY4741_Daqr1 strains, harboring the cloning vector pGREG576 (v) or the
derived cgaqr1 expression plasmid pGREG_cgaqr1, in MM4 agar plates
by spot assays. Cell suspensions used to prepare the spots were 1:5 (b) and
1:25 (c) dilutions of the cell suspension used in (a). The inocula were prepared
as described in Section “Materials and Methods.” Images are representative
of at least three independent experiments.
in these cells, the C. glabrata transporter was similarly localized to
the plasmamembrane andmembrane vesicles. Cells were grown to
mid-exponential phase in minimal medium containing 0.5% glu-
cose and 0.1% galactose, and then transferred to the same medium
containing 0.1% glucose and 1% galactose, to promote protein
over-expression. At a standard OD600 nm of 0.5 ± 0.05, obtained
after around 5 h of incubation, cells were inspected through ﬂuo-
rescencemicroscopy andplasmamembrane andmembrane vesicle
localization was veriﬁed (Figure 6B).
CgAqr1 PLAYS A ROLE IN REDUCING THE INTRACELLULAR
ACCUMULATION OF 3H-ﬂucytosine, BUT NOT OF 3H-CLOTRIMAZOLE OR
14C-ACETIC ACID IN C. glabrata
Since the C. glabrata gene CgAqr1, was found herein to encode a
drug resistance transporter of the plasma membrane, and of what
appears to be the membrane of exocytic vesicles, and to act as a
determinant of resistance to ﬂucytosine, acetic acid, and less sig-
niﬁcantly, clotrimazole, its possible involvement in reducing the
accumulation of these compounds in challenged yeast cells was
examined. The accumulation of radiolabeled ﬂucytosine was seen
to be four times higher in cells devoid of CgAqr1 than in wild-type
cells (Figure 7A), correlating with the strong effect of CgAQR1
deletion in ﬂucytosine resistance (Figure 3). The accumulation of
[3H]-labeled clotrimazole in non-adapted C. glabrata cells sud-
denly exposed to the presence of 30 mg/l cold clotrimazole was
also tested and found to be slightly higher than in cells devoid of
CgAqr1 than in parental KUE100 cells (Figure 7B), which appears
to be consistent with the relatively small difference in growth
inhibition exhibited by wild-type and Dcgaqr1 cells. Surprisingly,
no clear difference in 14C-acetic acid accumulation could be
found in wild-type and Dcgaqr1 strains (Figure 7C). These results
strongly suggests that CgAqr1 activity increases yeast resistance
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FIGURE 5 | Comparison of the growth curves of C. glabrata KUE100 ()
and KUE100_Dcgaqr1 () strains, in liquid BM medium, in the presence
of clotrimazole, acetic acid, or flucytosine (on the right) or in the
simultaneous presence of acetic acid and clotrimazole or acetic acid and
flucytosine (on the left), at the indicated concentrations.The inocula
were prepared as described in Section “Materials and Methods.” The
displayed growth curves are representative of at least three independent
experiments.
toward ﬂucytosine by reducing its accumulation within yeast cells,
presumably by catalyzing the direct extrusion of this antifungal
drug, while its action in acetic acid stress tolerancemay be indirect.
CgAqr1 TRANSCRIPT LEVELS ARE NOT UP-REGULATED UNDER ACETIC
ACID, CLOTRIMAZOLE, OR FLUCYTOSINE STRESS
The effect of C. glabrata cell exposure to inhibitory concentra-
tions of acetic acid, clotrimazole or ﬂucytosine, to which CgAqr1
confers resistance, in CgAqr1 transcription was evaluated. The
transcript levels of CgAqr1 gene were seen to suffer no signiﬁcant
change upon 1 h of exposure of an un-adapted C. glabrata popu-
lation to inhibitory concentrations of acetic acid, clotrimazole or
ﬂucytosine (Figure 8).
ACETIC ACID DOES NOT PROVIDE CROSS-PROTECTION AGAINST
CLOTRIMAZOLE AND FLUCYTOSINE
Given that CgAqr1 provides C. glabrata protection against acetic
acid, ﬂucytosine, and clotrimazole, the possibility that exposure to
each of these stress agents might confer cross-protection against
the remaining was hypothesized. To evaluate this possibility,
C. glabrata cells were pre-exposed to 60 mM of acetic acid, 50 mg/l
of clotrimazole, and 0.5 mg/l of ﬂucytosine and cultivated until
mid-exponential phase was reached (OD600 nm = 1.5 ± 0.05).
These cells, growing exponentially in the presence of each of these
stress agents were then harvested, washed, and exposed to the
three growth inhibitors as secondary stress agents. Pre-exposure
to acetic acid made C. glabrata cells able to growth at maximal
exponential rate upon re-exposure to the same concentration of
the acid, but did not increase yeast resistance to clotrimazole or
ﬂucytosine (Figure 9). On the other hand, pre-exposure to clotri-
mazole appears to have no protective effect against ﬂucytosine
or, not even, to re-exposure to clotrimazole itself, and to induce
a sensitization against post-exposure to acetic acid (Figure 9).
Finally, pre-exposure to ﬂucytosine, while making C. glabrata cells
tolerant to re-exposure to ﬂucytosine did actually make the cells
more susceptible to acetic acid and clotrimazole (Figure 9).
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FIGURE 6 | Fluorescence of exponential phase L5U1 C. glabrata
cells (A) or BY4741 S. cerevisiae cells (B), harboring the cloning
vector pGREG576 (control) or the pGREG576_CgAqr1 or pGREG576_
MTI_CgAqr1 plasmids (CgAqr1_GFP), after 5 h of galactose- or
copper-induced recombinant protein production, respectively.
Results indicate that the CgAqr1-GFP fusion protein localizes to the plasma
membrane and membrane vesicles in both S. cerevisiae and C. glabrata
cells.
DISCUSSION
In this study, the functional characterization of the C. glabrata
CgAqr1 drug:H+ antiporter was carried out. CgAqr1 was identi-
ﬁed as the ﬁrst of its family to confer resistance in this species to
the antifungal drug ﬂucytosine, but also to acetic acid.
To the best of our knowledge, no multidrug resistance trans-
porter had ever been linked to ﬂucytosine resistance. This is quite
surprising, considering that it has been known for some time
that the acquisition of ﬂucytosine resistance among clinical iso-
lates occurs very fast, which appears to be compatible with the
action of drug efﬂux pumps (Thompson et al., 2009). In most
cases, ﬂucytosine resistance has been associated to point muta-
tions or changes in the expression of the genes involved in the
uptake (e.g., carried out by cytosine permeases, such as Fcy2)
and catabolism (the ﬁrst step carried out by cytosine deaminase
Fcy1) of this antifungal pro-drug (Hope et al., 2004). Signiﬁcantly,
results from this study point out to a direct role of CgAqr1 in ﬂucy-
tosine efﬂux. Indeed, the increased ﬂucytosine resistance observed
in cells expressing the CgAQR1 gene, when compared to Dcgaqr1
deletion mutant cells, appears to correlate with the observation
that the accumulation of this antifungal drug is twofold higher
in the deletion mutant, when compared to the corresponding
parental strain. The results displayed herein further highlight
the unexplored role of drug efﬂux pumps in the context of
ﬂucytosine resistance.
CgAqr1 was also found to confer, to a lower level, resistance to
azole drugs, including the imidazolesmiconazole, tioconazole, and
clotrimazole, used in the treatment of fungal skin infections and
vaginal or oral candidemia. In C. glabrata, resistance to azole drugs
in clinical isolates has been shown to depend often on the action
of the ABC drug efﬂux pumps encoded by CgCDR1, CgCDR2,
and CgAUS1 (Cannon et al., 2009). Very recently, the C. glabrata
CgQdr2 drug:H+ antiporter was identiﬁed as the ﬁrst of its fam-
ily to confer imidazole drug resistance, playing a direct role in
the extrusion of clotrimazole (Costa et al., 2013). In this study,
CgAqr1 is added to the number of characterized Candida trans-
porters involved in azole drug resistance. However, the deletion of
CgAQR1 was found to have only a slight effect on 3H-clotrimazole
accumulation in C. glabrata cells, consistent with the moderate
increase in susceptibility registered upon CgAQR1 deletion.
Based on its high degree of homology and functional similar-
ity to the S. cerevisiae AQR1 gene, a possible physiological role
for CgAqr1 linked to yeast survival in the presence of inhibitory
concentrations of acetic acid (Tenreiro et al., 2002) was also
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FIGURE 7 |Time course accumulation ratio of [3H]-flucytosine (A),
[3H]-clotrimazole (B), and [14C]-acetate (C) in non-adapted cells of
KUE100 () or KUE100_Dcgaqr1 () strains, during cultivation in BM
liquid medium in the presence of 3 mg/l, 30 mg/l, or 100 mM of
unlabeled flucytosine, clotrimazole, or acetic acid, respectively.
The accumulation ratio values are averages of at least three independent
experiments. Error bars represent the corresponding standard
deviations.
FIGURE 8 | Comparison of the variation of the CgAQR1 transcript
levels in wild-type C. glabrata cells before (control) and after 1 h of
exposure to acetic acid-, clotrimazole-, or flucytosine-induced stress,
at the indicated concentrations.The presented transcript levels were
obtained by quantitative RT-PCR, as described in Section “Materials and
Methods,” and are relative CgAQR1/CgACT1 mRNA values, considering the
value registered in control conditions, equal to 1. The obtained values are
the average of at least three independent experiments. Error bars
represent the corresponding standard deviations.
inspected. Indeed, CgAqr1 expression did improve C. glabrata and
S. cerevisiae ﬁtness under inhibitory concentrations of this weak
carboxylic acid, and complemented the S. cerevisiae Daqr1 sus-
ceptibility phenotype observed in these conditions. ScAqr1 and
CgAqr1 were further found to confer ﬂucytosine resistance in
S. cerevisiae, CgAqr1 being able to complement the absence of
its S. cerevisiae counterpart under ﬂucytosine stress. The notion
that ScAqr1 and CgAqr1 may have overlapping functions is rein-
forced by the ﬁnding that their sub-cellular localization is also
quite similar, while different from that of the remaining mem-
bers of their family (Sá-Correia et al., 2009). Indeed, similar
to what had been registered for ScAqr1 (Tenreiro et al., 2002;
Velasco et al., 2004), CgAqr1 was found to be localized to both
the plasma membrane and membrane vesicles, being proposed to
catalyze the extrusion of its substrates across the plasma mem-
brane or through exocytic vesicles. The possibility that CgAqr1
displays as physiological role the catalysis of acetate excretion
was further investigated, but no effect of CgAQR1 expression on
14C-acetate accumulation could be detected. Signiﬁcantly, the
expression of the S. cerevisiae Aqr1 transporter had also been
found to have no effect on acetate transport (Tenreiro et al.,
2002). Although the exact role of CgAqr1 in acetic acid resis-
tance remains to be perceived, it may be indirectly due to the
transport of a still unidentiﬁed physiological substrate. Since
ScAqr1 was seen to be involved in the excretion of amino acids,
particularly homoserine, threonine, alanine, aspartate, and glu-
tamate (Velasco et al., 2004), it is reasonable to hypothesize that
a similar trait may be exhibited by its ortholog in C. glabrata.
Although it appears difﬁcult to foresee how exactly amino acid
excretion may contribute to acetic acid and azole drug resis-
tance, the truth is that the molecular mechanisms behind the
apparent promiscuity exhibited by MDR transporters of the ABC
and MFS superfamilies remains elusive and controversial (Roepe
et al., 1996; Prasad et al., 2002; Sá-Correia and Tenreiro, 2002;
Paulsen, 2003; Jungwirth and Kuchler, 2006; Sá-Correia et al.,
2009). Furthermore, the fact that some of the compounds to
whichmultidrug transporters confer resistance to are not extruded
through their direct action has been observed for the major-
ity of the ABC and MFS–MDR transporters characterized in S.
cerevisiae (Jungwirth and Kuchler, 2006; Sá-Correia et al., 2009),
whereas they have been found to be involved in the transport
of physiological substrates, including membrane lipids and ions
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FIGURE 9 | Comparison of the growth curves of C. glabrata KUE100
strain, in liquid BM medium, in the absence (♦) or presence of acetic
acid, clotrimazole, or flucytosine (,•), as indicated on the left.The
inocula were prepared as described in Section “Materials and Methods,”
from exponentially growing cells that were growing in control conditions (),
or that were pre-adapted (•) to the stress inducer indicated on the top. The
displayed growth curves are representative of at least three independent
experiments.
that in turn affect the plasma membrane partition, permeabil-
ity or toxicity of drugs, and xenobiotics (Vargas et al., 2007;
Cabrito et al., 2011; Teixeira et al., 2011, 2012). Such a possi-
ble scenario can also be envisaged to explain how CgAqr1 may
confer acetic acid resistance, without affecting its intracellular
accumulation.
Tolerance against weak acids is an important feature for
Candida species to thrive in the acidic environment (pH ∼ 4)
of the vaginal tract, where signiﬁcant concentrations of acetic and
lactic acids can be found (Davis, 2009). Furthermore, C. glabrata
is able to survive inside the phagolysosome, where it has to deal
with hydrolytic enzymes and an acidic environment. Results from
this study point out to the existence of a synergistic action between
both ﬂucytosine and clotrimazole and acetic acid, a phenomenon
observed previously between acetic acid and ﬂuconazole inC. albi-
cans (Moosa et al., 2004), reinforcing the importance of weak acid
resistance mechanisms in the context of antifungal therapy. This
effect, coupledwith the dual role of CgAqr1 in acetic acid and anti-
fungal drug resistance led us to hypothesize that pre-exposure of C.
glabrata cells to acetic acid concentrations similar to those found
in the vaginal tract might contribute to make them more tolerant
to antifungal drugs. However, the predicted cross-resistance effect
was not observed. Indeed, pre-exposure to acetic acid had no effect
on the susceptibility of C. glabrata cells to ﬂucytosine or clotri-
mazole, whereas pre-exposure to clotrimazole and ﬂucytosine
sensitizes these cells toward acetic acid stress. Interestingly,
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CgAqr1 transcript levels in C. glabrata were seen to be irrespon-
sive to chemical stress exposure, either that induced by acetic
acid, ﬂucytosine, or clotrimazole, suggesting that other genes
or post-translation regulatory effects may underlie the antifun-
gal drug-induced sensitization of C. glabrata cells. The fact that
CgAqr1 confers resistance to both antifungal drugs and acetic
acid strongly suggests that this transporter may play an impor-
tant role in the persistence of C. glabrata infections in acidic
loci.
Interestingly, the deletion of CgAQR1 was found to play a
major role in decreasing stress-induced lag-phase duration, while
having only a moderate effect in C. glabrata maximal growth
rate in the presence of ﬂucytosine, acetic acid, or clotrimazole.
A similar phenomenon was observed for most of the CgAqr1
homologs in S. cerevisiae (Sá-Correia et al., 2009). The current
model to explain this phenotype proposes that drug efﬂux pumps
are mostly required to deal with sudden exposure to chemical
stress. Additional mechanisms leading to the impermeabilization
of the cell envelope are reported to be activated upon chemi-
cal stress exposure, preventing drug re-entrance, and relieving
the requirement for the energy expensive process of extruding
drugs (Simões et al., 2003; Viegas et al., 2005). This model justi-
ﬁes the fact that drug efﬂux pumps appear to be required to a
lower extent during exponential growth in the presence of stress,
even when the stress agent is not degraded or neutralized. Indeed,
no catabolism of clotrimazole or acetic acid, in the presence of
glucose, is registered in yeast cells (Prasad et al., 2002; Guerreiro
et al., 2012). Thus, when a new population is suddenly exposed
to the vaginal environment or antifungal therapy or, more sig-
niﬁcantly, the two stresses at the same time, the expression of
Aqr1 appears to be important to the success of colonization and
persistence, but is not the single factor leading to chemical stress
resistance.
This study, characterizing theC. glabrataAqr1multidrug trans-
porter involved in ﬂucytosine and azole drug resistance, highlights
the importance of studying the remaining members of this family
in C. glabrata in this context, with an expected impact in the treat-
ment of the increasing number of drug resistant fungal infections.
Signiﬁcantly, CgAqr1 has close homologues in other pathogenic
Candida species, e.g., orf19.9520 from C. albicans, CPAR2_501800
from C. parapsilosis or Cd36_51250 from C. dubliniensis, which
may also play a role in acetic acid and antifungal drug resis-
tance in these related pathogenic yeasts. So far, only the drug:H+
antiporters Mdr1 and Flu1, from C. albicans (Goldway et al., 1995;
Calabrese et al., 2000),CgQdr2 fromC. glabrata (Costa et al., 2013)
and Mdr1 from C. dubliniensis (Sullivan et al., 2004) have been
linked to antifungal drug resistance, more speciﬁcally to azoles.
In C. glabrata, there are 15 predicted DHA transporters, of which
10 belong to the DHA1 family, predicted to have 12 transmem-
brane spanners, and 5 to the DHA2 family, predicted to have 14
transmembrane segments (Gbelska et al., 2006). The expectation
that these transporters, that remain so far mostly uncharacterized,
may play a signiﬁcant role in multidrug resistance in C. glabrata is
reinforced by the ﬁndings of this study.
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